ASMD Community Survey
As olipudase alfa moves through the regulatory process, we are proactively preparing for the next steps, which include speaking with insurance companies and ensuring reimbursement and coverage for patients across the country. To help us better understand our ASMD population, can you please take a moment to complete the following brief survey?
All data gathered in this survey will be anonymized. This survey will close on July 11th.